Qorvo (QRVO) 10-Q1 Feb 242024 Q3 Quarterly reportFinancial data

Company Profile

Cover Page

Cover Page - shares	9 Months Ended
Cover Page - shares	Dec. 30, 2023	Jan. 25, 2024
Cover [Abstract]
Document Transition Report	false
Document Quarterly Report	true
Title of 12(b) Security	Common Stock, $0.0001 par value
Entity Current Reporting Status	Yes
Entity Incorporation, State or Country Code	DE
Entity Registrant Name	Qorvo, Inc.
City Area Code	336
Entity Central Index Key	0001604778
Document Type	10-Q
Document Period End Date	Dec. 30, 2023
Entity File Number	001-36801
Amendment Flag	false
Document Fiscal Period Focus	Q3
Current Fiscal Year End Date	--03-30
Entity Filer Category	Large Accelerated Filer
Entity Emerging Growth Company	false
Entity Small Business	false
Entity Common Stock, Shares Outstanding		96,548,458
Entity Address, Address Line One	7628 Thorndike Road
Local Phone Number	664-1233
Entity Interactive Data Current	Yes
Entity Shell Company	false
Trading Symbol	QRVO
Security Exchange Name	NASDAQ
Entity Tax Identification Number	46-5288992
Entity Address, City or Town	Greensboro,
Entity Address, State or Province	NC
Entity Address, Postal Zip Code	27409-9421
Document Fiscal Year Focus	2024

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Dec. 30, 2023	Apr. 01, 2023
Current assets:
Cash and cash equivalents	$ 1,071,987	$ 808,757
Accounts receivable, net of allowance of $432 and $369 as of December 30, 2023 and April 1, 2023, respectively	483,810	304,519
Inventories	726,687	796,596
Prepaid expenses	39,575	46,684
Other Receivables, Net, Current	30,855	26,535
Other current assets	75,454	46,703
Total current assets	2,428,368	2,029,794
Property and equipment, net of accumulated depreciation of $2,017,964 and $1,900,317 as of December 30, 2023 and April 1, 2023, respectively	1,039,439	1,149,806
Goodwill	2,540,461	2,760,813
Intangible assets, net	499,963	537,703
Long-term investments	24,714	20,406
Other non-current assets	166,443	193,381
Total assets	6,699,388	6,691,903
Current liabilities:
Accounts payable	282,954	210,701
Accrued liabilities	327,485	222,463
Long-term Debt, Current Maturities	479,964	310
Other current liabilities	189,930	122,289
Total current liabilities	1,280,333	555,763
Long-Term Debt, Excluding Current Maturities	1,550,438	2,048,073
Other long-term liabilities	230,270	185,273
Total liabilities	3,061,041	2,789,109
Stockholders’ equity:
Preferred stock, $.0001 par value; 5,000 shares authorized; no shares issued and outstanding	0	0
Common stock and additional paid-in capital, $.0001 par value; 405,000 shares authorized; 96,680 and 98,649 shares issued and outstanding at December 30, 2023 and April 1, 2023, respectively	3,730,577	3,821,474
Accumulated other comprehensive income (loss)	102	(3,175)
(Accumulated deficit) retained earnings	(92,332)	84,495
Total stockholders’ equity	3,638,347	3,902,794
Total liabilities and stockholders’ equity	$ 6,699,388	$ 6,691,903

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - USD ($) $ in Thousands	Dec. 30, 2023	Apr. 01, 2023
Statement of Financial Position [Abstract]
Common stock, shares outstanding	96,680,000	98,649,000
Accounts Receivable, Allowance for Credit Loss, Current	$ 432	$ 369
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment	$ 2,017,964	$ 1,900,317
Preferred Stock, par value	$ 0.0001	$ 0.0001
Preferred Stock, Shares Authorized	5,000,000	5,000,000
Preferred Stock, Shares Issued	0	0
Preferred Stock, Shares Outstanding	0	0
Common Stock, par value	$ 0.0001	$ 0.0001
Common Stock, Shares Authorized	405,000,000	405,000,000
Common Stock, Shares, Issued	96,680,000	98,649,000

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 30, 2023	Dec. 31, 2022	Dec. 30, 2023	Dec. 31, 2022
Income Statement [Abstract]
Revenues	$ 1,073,861	$ 743,281	$ 2,828,518	$ 2,936,696
Cost of goods sold	685,983	475,230	1,721,880	1,754,468
Gross profit	387,878	268,051	1,106,638	1,182,228
Operating Expenses [Abstract]
Research and Development Expense	164,329	149,472	502,366	486,204
Selling, general and administrative	86,914	76,269	296,033	275,836
Other operating expense	178,204	33,581	246,516	48,038
Total operating expenses	429,447	259,322	1,044,915	810,078
Operating (loss) income	(41,569)	8,729	61,723	372,150
Interest expense	(17,581)	(17,066)	(51,963)	(51,222)
Other income (expense), net	15,359	5,562	34,286	2,714
Loss before income taxes	(43,791)	(2,775)	44,046	323,642
Income tax benefit (expense)	(83,147)	(13,156)	(117,103)	(82,074)
Net loss	$ (126,938)	$ (15,931)	$ (73,057)	$ 241,568
Earnings Per Share [Abstract]
Basic	$ (1.31)	$ (0.16)	$ (0.75)	$ 2.34
Diluted	$ (1.31)	$ (0.16)	$ (0.75)	$ 2.33
Weighted Average Number of Shares Outstanding, Diluted [Abstract]
Basic	97,152	100,943	97,905	103,039
Diluted	97,152	100,943	97,905	103,812

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 30, 2023	Dec. 31, 2022	Dec. 30, 2023	Dec. 31, 2022
Statement of Comprehensive Income [Abstract]
Net (loss) income	$ (126,938)	$ (15,931)	$ (73,057)	$ 241,568
Other comprehensive income, net of tax:
Foreign currency translation adjustment, including intra-entity foreign currency transactions that are of a long-term investment nature	13,714	30,403	3,286	(16,623)
Reclassification adjustments, net of tax:
Amortization of pension actuarial (gain) loss	(3)	8	(9)	26
Other comprehensive income	13,711	30,411	3,277	(16,597)
Total comprehensive (loss) income	$ (113,227)	$ 14,480	$ (69,780)	$ 224,971

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock	Accumulated Other Comprehensive Loss	Retained Earnings [Member]
Common Stock, Shares, Outstanding		106,303
Common stock and additional paid-in capital	$ 4,035,849
Stockholders' Equity Attributable to Parent	4,553,218
Accumulated Other Comprehensive Income (Loss), Net of Tax	5,232
Retained Earnings (Accumulated Deficit)	512,137
Net (loss) income	241,568	$ 0	$ 0	$ 241,568
Other Comprehensive Income (Loss), Net of Tax	(16,597)	$ 0	(16,597)	0
Exercise Of Stock Options And Vesting Of Restricted Stock Units Net Of Shares Withheld For Employee Taxes Shares		550
Exercise Of Stock Options And Vesting Of Restricted Stock Units Net Of Shares Withheld For Employee Taxes	(21,502)	$ (21,502)	0	0
Stock Issued During Period, Shares, Employee Stock Purchase Plans		345
Stock Issued During Period, Value, Employee Stock Purchase Plan	$ 30,169	$ 30,169	0	0
Stock Repurchased During Period, Shares	(7,200)	(7,177)
Stock Repurchased During Period, Value	$ (711,732)	$ (274,020)	0	(437,712)
Stock-based compensation	89,444	$ 89,444	0	0
Payments for Repurchase of Common Stock	711,732
Common Stock, Shares, Outstanding		102,061
Common stock and additional paid-in capital	3,915,969
Stockholders' Equity Attributable to Parent	4,322,140
Accumulated Other Comprehensive Income (Loss), Net of Tax	(41,776)
Retained Earnings (Accumulated Deficit)	447,947
Net (loss) income	(15,931)	$ 0	0	(15,931)
Other Comprehensive Income (Loss), Net of Tax	30,411	$ 0	30,411	0
Exercise Of Stock Options And Vesting Of Restricted Stock Units Net Of Shares Withheld For Employee Taxes Shares		41
Exercise Of Stock Options And Vesting Of Restricted Stock Units Net Of Shares Withheld For Employee Taxes	(321)	$ (321)	0	0
Stock Issued During Period, Shares, Employee Stock Purchase Plans		150
Stock Issued During Period, Value, Employee Stock Purchase Plan	$ 11,276	$ 11,276	0	0
Stock Repurchased During Period, Shares	(2,200)	(2,231)
Stock Repurchased During Period, Value	$ (201,633)	$ (85,610)	0	(116,023)
Stock-based compensation	$ 18,626	$ 18,626	0	0
Common Stock, Shares, Outstanding	100,021	100,021
Common stock and additional paid-in capital	$ 3,859,940
Stockholders' Equity Attributable to Parent	4,164,568
Accumulated Other Comprehensive Income (Loss), Net of Tax	(11,365)
Retained Earnings (Accumulated Deficit)	$ 315,993
Common Stock, Shares, Outstanding	98,649
Common stock and additional paid-in capital	$ 3,821,474
Stockholders' Equity Attributable to Parent	3,902,794
Accumulated Other Comprehensive Income (Loss), Net of Tax	(3,175)
Retained Earnings (Accumulated Deficit)	84,495
Net (loss) income	(73,057)	$ 0	0	(73,057)
Other Comprehensive Income (Loss), Net of Tax	3,277	$ 0	3,277	0
Exercise Of Stock Options And Vesting Of Restricted Stock Units Net Of Shares Withheld For Employee Taxes Shares		616
Exercise Of Stock Options And Vesting Of Restricted Stock Units Net Of Shares Withheld For Employee Taxes	(25,010)	$ (25,010)	0	0
Stock Issued During Period, Shares, Employee Stock Purchase Plans		479
Stock Issued During Period, Value, Employee Stock Purchase Plan	$ 35,045	$ 35,045	0	0
Stock Repurchased During Period, Shares	(3,100)	(3,064)
Stock Repurchased During Period, Value	$ (301,978)	$ (198,208)	0	(103,770)
Stock-based compensation	97,276	$ 97,276	0	0
Payments for Repurchase of Common Stock	300,043
Common Stock, Shares, Outstanding		97,506
Common stock and additional paid-in capital	3,796,189
Stockholders' Equity Attributable to Parent	3,817,186
Accumulated Other Comprehensive Income (Loss), Net of Tax	(13,609)
Retained Earnings (Accumulated Deficit)	34,606
Net (loss) income	(126,938)	$ 0	0	(126,938)
Other Comprehensive Income (Loss), Net of Tax	13,711	$ 0	13,711	0
Exercise Of Stock Options And Vesting Of Restricted Stock Units Net Of Shares Withheld For Employee Taxes Shares		19
Exercise Of Stock Options And Vesting Of Restricted Stock Units Net Of Shares Withheld For Employee Taxes	(847)	$ (847)	0	0
Stock Issued During Period, Shares, Employee Stock Purchase Plans		217
Stock Issued During Period, Value, Employee Stock Purchase Plan	$ 15,865	$ 15,865	0	0
Stock Repurchased During Period, Shares	(1,100)	(1,062)
Stock Repurchased During Period, Value	$ (100,812)	$ (100,812)	0	0
Stock-based compensation	$ 20,182	$ 20,182	$ 0	$ 0
Common Stock, Shares, Outstanding	96,680
Common stock and additional paid-in capital	$ 3,730,577
Stockholders' Equity Attributable to Parent	3,638,347
Accumulated Other Comprehensive Income (Loss), Net of Tax	102
Retained Earnings (Accumulated Deficit)	$ (92,332)

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Dec. 30, 2023	Dec. 31, 2022
Cash flows from operating activities:
Net (loss) income	$ (73,057)	$ 241,568
Adjustments to reconcile net (loss) income to net cash provided by operating activities:
Depreciation	146,841	155,132
Intangible assets amortization	92,308	99,476
Deferred income taxes	62,365	(2,557)
Goodwill, Impairment Loss	221,414	0
Stock-based compensation expense	99,253	86,911
Other, net	24,453	95,459
Changes in operating assets and liabilities:
Accounts receivable, net	(179,315)	201,823
Inventories	66,190	(98,882)
Prepaid expenses and other assets	(10,312)	42,979
Accounts payable and accrued liabilities	183,091	(85,321)
Income taxes payable and receivable	(9,408)	(17,281)
Other liabilities	7,022	58,481
Net cash provided by operating activities	630,845	777,788
Cash flows from investing activities:
Purchase of property and equipment	(94,514)	(124,853)
Proceeds from Sale of Property, Plant, and Equipment	47,446	581
Other investing activities	23,777	6,914
Net cash used in investing activities	(23,291)	(117,358)
Cash flows from financing activities:
Repurchase of common stock, including transaction costs	(300,043)	(711,732)
Proceeds from the issuance of common stock	26,358	20,828
Tax withholding paid on behalf of employees for restricted stock units	(26,318)	(22,687)
Repayments of Debt	17,914	0
Other financing activities	(9,933)	(422)
Net cash used in financing activities	(327,850)	(714,013)
Net increase (decrease) in cash, cash equivalents and restricted cash	283,044	(53,863)
Cash, cash equivalents and restricted cash at the beginning of the period	808,943	972,805
Cash, cash equivalents and restricted cash at the end of the period	1,091,987	918,942
Effect of exchange rate changes on cash, cash equivalents and restricted cash	3,340	(280)
Cash and cash equivalents	1,071,987	918,758
Restricted cash included in "Other current assets" and "Other non-current assets"	20,000	184
Capital expenditures included in liabilities	$ 77,704	$ 26,597

Basis of Presentation and Signi

Basis of Presentation and Significant Accounting Policies	9 Months Ended
Basis of Presentation and Significant Accounting Policies	Dec. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES	BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES The accompanying Condensed Consolidated Financial Statements of Qorvo, Inc. and Subsidiaries (together, the "Company" or "Qorvo") have been prepared in conformity with accounting principles generally accepted in the United States ("U.S. GAAP"). The preparation of these financial statements requires management to make estimates and assumptions, which could differ materially from actual results. In addition, certain information or footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed, or omitted, pursuant to the rules and regulations of the United States Securities and Exchange Commission (the "SEC"). In the opinion of management, the financial statements include all adjustments (which are of a normal and recurring nature) necessary for the fair presentation of the results of the interim periods presented. These Condensed Consolidated Financial Statements should be read in conjunction with the Company's audited consolidated financial statements and notes thereto included in Qorvo’s Annual Report on Form 10-K for the fiscal year ended April 1, 2023. The Condensed Consolidated Financial Statements include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation. The Company operates under three segments, High Performance Analog ("HPA"), Connectivity and Sensors Group ("CSG") and Advanced Cellular Group ("ACG"). Certain prior period amounts have been reclassified to conform to the fiscal 2024 presentation. The Company uses a 52- or 53-week fiscal year ending on the Saturday closest to March 31 of each year. Each fiscal year, the first quarter ends on the Saturday closest to June 30, the second quarter ends on the Saturday closest to September 30 and the third quarter ends on the Saturday closest to December 31. Fiscal years 2024 and 2023 are 52-week years.

Inventories

Inventories	9 Months Ended
Inventories	Dec. 30, 2023
Inventory Disclosure [Abstract]
INVENTORIES	INVENTORIES The components of inventories, net of reserves, are as follows (in thousands): December 30, 2023 April 1, 2023 Raw materials $ 214,530 $ 264,367 Work in process 372,554 345,545 Finished goods 139,603 186,684 Total inventories $ 726,687 $ 796,596

Goodwill and Intangible Assets

Goodwill and Intangible Assets	9 Months Ended
Goodwill and Intangible Assets	Dec. 30, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Intangible Assets Disclosure [Text Block]	GOODWILL AND INTANGIBLE ASSETS The changes in the carrying amount of goodwill are as follows (in thousands): HPA CSG ACG Total Balance as of April 1, 2023 (1) $ 501,602 $ 525,351 $ 1,733,860 $ 2,760,813 Goodwill impairment — (221,414) — (221,414) Effect of changes in foreign currency exchange rates — 1,062 — 1,062 Balance as of December 30, 2023 (1) $ 501,602 $ 304,999 $ 1,733,860 $ 2,540,461 (1) The Company’s goodwill balance is presented net of accumulated impairment losses and write-offs totaling $903.4 million and $682.0 million as of December 30, 2023 and April 1, 2023, respectively, which were recognized in fiscal years 2009, 2013, 2014, 2022, 2023 and 2024. During the second quarter of fiscal 2024, the Company completed an interim test for goodwill impairment as management determined, based on revisions to long-term forecasts, it was more likely than not that the fair value of a reporting unit within the CSG segment was below its carrying amount. The quantitative analysis, which considered the income approach and the market approach to estimate the reporting unit's fair value, resulted in a goodwill impairment charge of approximately $48.0 million. In the third quarter of fiscal 2024, the Company concluded that an impairment triggering event occurred for this same reporting unit within the CSG segment as new information was received regarding slower than expected market adoption for one of CSG's new technologies and lower attach rates for a second CSG technology (resulting in further revisions to the long-term forecasts of this reporting unit). The Company concluded that it was more likely than not that the fair value of this reporting unit was below its carrying amount, and a quantitative analysis was performed. The quantitative analysis, which considered the income approach and the market approach to estimate the reporting unit's fair value, resulted in a goodwill impairment charge of approximately $173.4 million. These goodwill impairment charges are recorded in "Other operating expense" in the Condensed Consolidated Statements of Operations. The following summarizes information regarding the gross carrying amounts and accumulated amortization of intangible assets (in thousands): December 30, 2023 April 1, 2023 Gross Accumulated Gross Accumulated Developed technology $ 876,285 $ 462,259 $ 872,106 $ 382,448 Customer relationships 87,040 62,872 104,616 67,485 Technology licenses 54,287 2,128 1,664 513 Trade names 910 910 910 789 In-process research and development 9,610 N/A 9,642 N/A Total (1) $ 1,028,132 $ 528,169 $ 988,938 $ 451,235 (1) Amounts include the impact of foreign currency translation. At the beginning of each fiscal year, the Company removes the gross asset and accumulated amortization amounts of intangible assets that have reached the end of their useful lives and have been fully amortized. Useful lives are estimated based on the expected economic benefit to be derived from the intangible assets.

Investments and Fair Value of F

Investments and Fair Value of Financial Instruments	9 Months Ended
Investments and Fair Value of Financial Instruments	Dec. 30, 2023
Investments and Fair Value Measurements [Abstract]
Investments and Fair Value Measurements [Text Block]	INVESTMENTS AND FAIR VALUE OF FINANCIAL INSTRUMENTS Equity Method Investments The Company invests in limited partnerships and accounts for these investments using the equity method. The carrying amounts of these investments, as of December 30, 2023 and April 1, 2023 were $17.5 million and $20.4 million, respectively, and are classified as "Long-term investments" in the Condensed Consolidated Balance Sheets. During the three and nine months ended December 30, 2023, the Company recorded a loss of $0.6 million and income of $0.3 million, respectively, based on its share of the limited partnerships' results. During the three and nine months ended December 31, 2022, the Company recorded losses of $5.0 million and $4.7 million, respectively, based on its share of the limited partnerships' results. These amounts are included in "Other income, net" in the Condensed Consolidated Statements of Operations. D uring the three and nine months ended December 30, 2023, the Company received cash distributions of $0.4 million and $3.2 million, respectively, from these limited partnerships. During the three and nine months ended December 31, 2022, the Company received cash distributions of $0.2 million and $2.2 million, respectively, from these limited partnerships. The cash distributions were recognized as reductions to the carrying value of the investments and included in the cash flows from investing activities in the Condensed Consolidated Statements of Cash Flows. Fair Value of Financial Instruments The following table sets forth, by level within the fair value hierarchy, financial assets and liabilities measured on a recurring basis (in thousands): Total Quoted Prices In Significant Other Significant December 30, 2023 Marketable equity securities $ 812 $ 812 $ — $ — Invested funds in deferred compensation plan (1) 48,386 48,386 — — April 1, 2023 Marketable equity securities $ 1,094 $ 1,094 $ — $ — Invested funds in deferred compensation plan (1) 40,653 40,653 — — Contingent earn-out liability (2) (31,250) — — (31,250) (1) Invested funds under the Company's non-qualified deferred compensation plan are held in a rabbi trust and consist of mutual funds. The fair value of the mutual funds is calculated using the net asset value per share determined by quoted active market prices of the underlying investments. (2) The fair value of the contingent consideration liability which related to the acquisition of United Silicon Carbide, Inc. was equal to the maximum amount payable at April 1, 2023 and was subsequently paid in the first quarter of fiscal 2024.

Long-Term Debt

Long-Term Debt	9 Months Ended
Long-Term Debt	Dec. 30, 2023
Debt Disclosure [Abstract]
DEBT	DEBT The following table summarizes the outstanding debt (in thousands): December 30, 2023 April 1, 2023 1.750% senior notes due 2024 $ 481,333 $ 500,000 4.375% senior notes due 2029 850,000 850,000 3.375% senior notes due 2031 700,000 700,000 Finance leases and other 1,255 1,666 Unamortized premium, discount and issuance costs, net (2,186) (3,283) Total debt 2,030,402 2,048,383 Less current portion of debt (479,964) (310) Total long-term debt $ 1,550,438 $ 2,048,073 Credit Agreement On September 29, 2020, the Company and certain of its U.S. subsidiaries (the "Guarantors") entered into a five-year unsecured senior credit facility pursuant to a credit agreement (as amended, restated, modified or otherwise supplemented from time to time, the "Credit Agreement") with Bank of America, N.A., acting as administrative agent, and a syndicate of lenders. The Credit Agreement amended and restated the previous credit agreement dated as of December 5, 2017. The Credit Agreement includes a senior revolving line of credit (the "Revolving Facility") of up to $300.0 million, and included a senior term loan that was fully repaid in fiscal 2022. The Revolving Facility is available to finance working capital, capital expenditures and other general corporate purposes. Pursuant to the Credit Agreement, the Company may request one or more additional tranches of term loans or increases to the Revolving Facility, up to an aggregate of $500.0 million and subject to, among other things, securing additional funding commitments from the existing or new lenders. On April 6, 2022, the Company and the administrative agent entered into an amendment to the Credit Agreement (the "LIBOR Transition Amendment") to replace the London Interbank Offered Rate as a reference rate available for use in the computation of interest under the Credit Agreement. As a result of the LIBOR Transition Amendment, at the Company’s option, loans under the Credit Agreement will bear interest at (i) the Applicable Rate (as defined in the Credit Agreement) plus the Term SOFR (as defined in the Credit Agreement) or (ii) the Applicable Rate plus a rate equal to the highest of (a) the federal funds rate plus 0.50%, (b) the prime rate as set by the administrative agent, and (c) the Term SOFR plus 1.0% (the "Base Rate"). All swing line loans will bear interest at a rate equal to the Applicable Rate plus the Base Rate. The Term SOFR is the rate per annum equal to the forward-looking Secured Overnight Financing Rate term rate for interest periods of one, three or six months (as selected by the Company) plus an adjustment (as defined in the Credit Agreement). The Applicable Rate for Term SOFR loans ranges from 1.000% per annum to 1.250% per annum, and the Applicable Rate for Base Rate loans ranges from 0.000% per annum to 0.250% per annum. Undrawn amounts under the Revolving Facility are subject to a commitment fee ranging from 0.150% to 0.200%. On June 23, 2023, the Company entered into a second amendment to the Credit Agreement (the "Second Amendment"). The purpose of the Second Amendment was to amend certain covenants related to the Company’s ratio of Consolidated Funded Indebtedness to Consolidated EBITDA, as such terms are defined in the Credit Agreement (the "Consolidated Leverage Ratio"). The Second Amendment increased the maximum Consolidated Leverage Ratio to 4.00 to 1.00 for the fiscal quarters ended July 1, 2023 and September 30, 2023, and 3.50 to 1.00 for the fiscal quarters ended December 30, 2023 and ending March 30, 2024. For subsequent fiscal quarters, the maximum Consolidated Leverage Ratio will return to 3.00 to 1.00. During the three and nine months ended December 30, 2023, there were no borrowings under the Revolving Facility. The Credit Agreement contains various conditions, covenants and representations with which the Company must be in compliance in order to borrow funds and to avoid an event of default. As of December 30, 2023, the Company was in compliance with these covenants. Senior Notes due 2024 On December 14, 2021, the Company issued $500.0 million aggregate principal amount of its 1.750% senior notes due 2024 (the "2024 Notes"). The 2024 Notes will mature on December 15, 2024, unless earlier redeemed in accordance with their terms. The 2024 Notes are senior unsecured obligations of the Company and are guaranteed, jointly and severally, by the Guarantors. The 2024 Notes were issued pursuant to an indenture, dated as of December 14, 2021 (the "2021 Indenture"), by and among the Company, the Guarantors and Computershare Trust Company, N.A., as trustee. The 2021 Indenture contains customary events of default, including payment default, exchange default, failure to provide certain notices thereunder and certain provisions related to bankruptcy events. The 2021 Indenture also contains customary negative covenants. In connection with the offering of the 2024 Notes, the Company agreed to provide the holders of the 2024 Notes with an opportunity to exchange the 2024 Notes for registered notes having terms substantially identical to the 2024 Notes. On November 24, 2023, the Company completed the exchange offer, in which substantially all of the privately placed 2024 Notes were exchanged for new notes that have been registered under the Securities Act of 1933, as amended. In December 2023, the Company repurchased $18.7 million of the principal amount of the 2024 Notes, plus accrued and unpaid interest, on the open market. The Company recognized a net gain on debt extinguishment of $0.7 million, which is included in "Other income, net" in the Condensed Consolidated Statements of Operations. The remaining principal amount of the 2024 Notes of $481.3 million is included in "Current portion of long-term debt" in the Condensed Consolidated Balance Sheet as of December 30, 2023. Interest is payable on the 2024 Notes on June 15 and December 15 of each year. The Company paid interest of $4.2 million and $8.6 million on the 2024 Notes during the three and nine months ended December 30, 2023, respectively, and paid interest of $4.4 million and $8.8 million on the 2024 Notes during the three and nine months ended December 31, 2022, respectively. Senior Notes due 2029 On September 30, 2019, the Company issued $350.0 million aggregate principal amount of its 4.375% senior notes due 2029 (the "Initial 2029 Notes"). On December 20, 2019, and June 11, 2020, the Company issued an additional $200.0 million and $300.0 million, respectively, aggregate principal amount of such notes (together, the "Additional 2029 Notes" and collectively with the Initial 2029 Notes, the "2029 Notes"). The 2029 Notes will mature on October 15, 2029, unless earlier redeemed in accordance with their terms. The 2029 Notes are senior unsecured obligations of the Company and are guaranteed, jointly and severally, by the Guarantors. The Initial 2029 Notes were issued pursuant to an indenture, dated as of September 30, 2019, by and among the Company, the Guarantors and MUFG Union Bank, N.A., as trustee, and the Additional 2029 Notes were issued pursuant to supplemental indentures, dated as of December 20, 2019, and June 11, 2020 (such indenture and supplemental indentures, collectively, the "2019 Indenture"). The 2019 Indenture contains substantially the same customary events of default and negative covenants as the 2021 Indenture. Interest is payable on the 2029 Notes on April 15 and October 15 of each year. The Company paid interest of $18.6 million on the 2029 Notes during both the three months ended December 30, 2023 and December 31, 2022, and paid interest of $37.2 million during both the nine months ended December 30, 2023 and December 31, 2022. Senior Notes due 2031 On September 29, 2020, the Company issued $700.0 million aggregate principal amount of its 3.375% senior notes due 2031 (the "2031 Notes"). The 2031 Notes will mature on April 1, 2031, unless earlier redeemed in accordance with their terms. The 2031 Notes are senior unsecured obligations of the Company and are guaranteed, jointly and severally, by the Guarantors. The 2031 Notes were issued pursuant to an indenture, dated as of September 29, 2020, by and among the Company, the Guarantors and MUFG Union Bank, N.A., as trustee (the "2020 Indenture"). The 2020 Indenture contains substantially the same customary events of default and negative covenants as the 2021 Indenture. Interest is payable on the 2031 Notes on April 1 and October 1 of each year. The Company paid interest of $11.8 million on the 2031 Notes during the three and nine months ended December 30, 2023. The Company paid no interest on the 2031 Notes during the three months ended December 31, 2022 and paid interest of $11.8 million during the nine months ended December 31, 2022. Fair Value of Debt The Company's debt is carried at amortized cost and is measured at fair value quarterly for disclosure purposes. The estimated fair value of the 2024 Notes, the 2029 Notes and the 2031 Notes as of December 30, 2023 was $462.1 million, $803.9 million and $602.2 million, respectively (compared to the outstanding principal amount of $481.3 million, $850.0 million and $700.0 million, respectively). The estimated fair value of the 2024 Notes, the 2029 Notes and the 2031 Notes as of April 1, 2023 was $464.2 million, $785.9 million and $565.3 million, respectively (compared to the outstanding principal amount of $500.0 million, $850.0 million and $700.0 million, respectively). The Company considers its debt to be Level 2 in the fair value hierarchy. Fair values are estimated based on quoted market prices for identical or similar instruments. The 2024 Notes, the 2029 Notes and the 2031 Notes currently trade over-the-counter, and the fair values were estimated based upon the value of the last trade at the end of the period. Interest Expense During the three and nine months ended December 30, 2023, the Company recognized $18.2 million and $54.2 million of interest expense , respectively, primarily related to the 2024 Notes, the 2029 Notes and the 2031 Notes, partially offset by interest capitalized to property and equipment of $0.6 million and $2.3 million , respectively. During the three and nine months ended December 31, 2022, the Company recognized $18.1 million and $54.2 million of interest expense, respectively, primarily related to the 2024 Notes, the 2029 Notes and the 2031 Notes, partially offset by interest capitalized to property and equipment of $1.0 million and $3.0 million, respectively.

Stock Repurchases

Stock Repurchases	9 Months Ended
Stock Repurchases	Dec. 30, 2023
Equity [Abstract]
STOCK REPURCHASES	STOCK REPURCHASES On November 2, 2022, the Company announced that its Board of Directors authorized a new share repurchase program to repurchase up to $2.0 billion of the Company's outstanding common stock, which included the remaining authorized dollar amount under a prior program terminated concurrent with the new authorization. Under the current program, share repurchases are made in accordance with applicable securities laws on the open market or in privately negotiated transactions. The extent to which the Company repurchases its shares, the number of shares and the timing of any repurchases depends on general market conditions, regulatory requirements, alternative investment opportunities and other considerations. The program does not require the Company to repurchase a minimum number of shares, does not have a fixed term, and may be modified, suspended, or terminated at any time without prior notice. As of January 1, 2023, the Company's share repurchases in excess of issuances are subject to a 1% excise tax enacted by the Inflation Reduction Act. The excise tax is recognized as part of the cost basis of shares acquired in the Condensed Consolidated Statements of Stockholders' Equity. During the three and nine months ended December 30, 2023, the Company repurchased approximately 1.1 million and 3.1 million shares of its common stock, respectively, for approximately $100.8 million and $302.0 million, respectively (including transaction costs and excise tax) under the current share repurchase program. As of December 30, 2023, approximately $1,405.0 million remains authorized for repurchases under the current share repurchase program. During the three and nine months ended December 31, 2022, the Company repurchased approximately 2.2 million and 7.2 million shares of its common stock, respectively, for approximately $201.6 million and $711.7 million, respectively (including transaction costs) under the prior and current share repurchase programs.

Commitments and Contingent Liab

Commitments and Contingent Liabilities	9 Months Ended
Commitments and Contingent Liabilities	Dec. 30, 2023
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies Disclosure [Text Block]	COMMITMENTS AND CONTINGENT LIABILITIES In fiscal 2022, the Company entered into a long-term capacity reservation agreement with a foundry supplier to purchase a certain number of wafers through calendar year 2025. In fiscal 2023, the agreement was amended, and the term was extended through calendar year 2026. In the first quarter of fiscal 2023, the Company recorded charges of $110.0 million to "Cost of goods sold" based on the actual and estimated purchase shortfalls. No charges were recorded to the Condensed Consolidated Statements of Operations in the first quarter or second quarter of fiscal 2024 as a result of this agreement. In October 2023, the agreement was further amended. Pursuant to the amendment, the Company is no longer obligated to order silicon wafers from the foundry supplier and the agreement was terminated effective December 31, 2023. A contract termination fee of $65.0 million, which is expected to be paid by the Company during the fourth quarter of fiscal 2024, was recorded to “Cost of goods sold” and "Other current liabilities" in the third quarter of fiscal 2024. Legal Matters The Company is involved in various legal proceedings and claims that have arisen in the ordinary course of business that have not been fully adjudicated. The Company accrues a liability for legal contingencies when it believes that it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated. The Company regularly evaluates developments in its legal matters that could affect the amount of the previously accrued liability and records adjustments as appropriate. Although it is not possible to predict with certainty the outcome of the unresolved legal matters, it is the opinion of management that these matters will not, individually or in the aggregate, have a material adverse effect on the Company’s consolidated financial position or results of operations. The aggregate range of reasonably possible losses in excess of accrued liabilities, if any, associated with these unresolved legal matters is not material.

Revenue

Revenue	9 Months Ended
Revenue	Dec. 30, 2023
Revenue from Contract with Customer [Abstract]
REVENUE	REVENUE Revenue to customers by geographic region (based on the location of the customers' headquarters) is summarized as follows (in thousands): Three Months Ended Nine Months Ended December 30, 2023 December 31, 2022 December 30, 2023 December 31, 2022 United States $ 652,477 $ 459,194 $ 1,667,048 $ 1,470,231 China 201,172 124,799 541,878 630,012 Other Asia 144,584 72,002 355,313 390,690 Taiwan 60,775 53,072 192,793 274,707 Europe 14,853 34,214 71,486 171,056 Total revenue $ 1,073,861 $ 743,281 $ 2,828,518 $ 2,936,696 The Company also disaggregates revenue by operating segments (refer to Note 10).

Restructuring and Related Activ

Restructuring and Related Activities	9 Months Ended
Restructuring and Related Activities	Dec. 30, 2023
Restructuring and Related Activities [Abstract]
RESTRUCTURING	RESTRUCTURING During fiscal 2023, the Company initiated actions to improve efficiencies in its operations and further align the organization with its strategic objectives. These initiatives (the "2023 Restructuring Initiatives") included seeking strategic alternatives related to its non-core biotechnology business. In the third quarter of fiscal 2024, the Company recognized a gain on the sale of its non-core biotechnology business, which is recorded in "Other operating expense" in the Condensed Consolidated Statements of Operations. The Company will continue to evaluate its operating footprint, cost structure and strategic opportunities, but does not expect to incur additional material charges related to the 2023 Restructuring Initiatives. As of December 30, 2023, the Company has incurred cumulative charges of $160.5 million related to the 2023 Restructuring Initiatives. The following tables summarize the charges resulting from the 2023 Restructuring Initiatives (in thousands): Three Months Ended December 30, 2023 Nine Months Ended December 30, 2023 Cost of Goods Sold Other Operating Expense Total Cost of Goods Sold Other Operating Expense Total Contract termination and other costs (1) $ (250) $ 773 $ 523 $ 19,028 $ 3,530 $ 22,558 Asset impairment costs (2) — 2,341 2,341 2,159 6,627 8,786 One-time employee termination benefits — 7 7 — 2,681 2,681 Total $ (250) $ 3,121 $ 2,871 $ 21,187 $ 12,838 $ 34,025 Three Months Ended December 31, 2022 Nine Months Ended December 31, 2022 Cost of Goods Sold Other Operating Expense Total Cost of Goods Sold Other Operating Expense Total Contract termination and other costs $ 3,600 $ 11,509 $ 15,109 $ 3,600 $ 13,433 $ 17,033 Asset impairment costs (2) — 12,899 12,899 — 12,899 12,899 One-time employee termination benefits (1) — (623) (623) — 2,547 2,547 Total $ 3,600 $ 23,785 $ 27,385 $ 3,600 $ 28,879 $ 32,479 (1) Includes reversal due to adjustment of previously accrued restructuring charges. (2) Includes the adjustment of certain property and equipment to reflect its fair value. In the third quarter of fiscal 2024, the Company entered into a definitive agreement with a global advanced contract manufacturer (the "Purchaser"), to sell its assembly and test facilities in Beijing and Dezhou, China (the "2024 Restructuring Initiative"). The transaction is expected to be completed in the first half of calendar 2024, subject to receipt of regulatory approvals and the satisfaction or waiver of other closing conditions. Assembly and test services will be provided to the Company by the Purchaser under a long-term supply agreement upon completion of the transaction. In connection with the 2024 Restructuring Initiative, t he Company incurred immaterial legal and professional fees, recorded to "Other operating expense," in the third quarter of fiscal 2024, and expects to incur additional restructuring-related charges related to this initiative. R estructuring charges recorded by the Company are not allocated to its reportable segments. The following table summarizes the activity related to the Company's restructuring liabilities for the nine months ended December 30, 2023 (in thousands): One-Time Employee Termination Benefits Contract Termination and Other Costs Total Accrued restructuring balance as of April 1, 2023 $ — $ 5,248 $ 5,248 Costs incurred and charged to expense 2,681 25,762 28,443 Cash payments (2,604) (16,571) (19,175) Accrued restructuring balance as of December 30, 2023 $ 77 $ 14,439 $ 14,516 The accrued restructuring balances as of December 30, 2023 represent estimated future cash payments required to satisfy the Company's remaining obligations, the majority of which are expected to be paid in the next twelve months.

Operating Segment Information

Operating Segment Information	9 Months Ended
Operating Segment Information	Dec. 30, 2023
Segment Reporting [Abstract]
OPERATING SEGMENT INFORMATION	OPERATING SEGMENT INFORMATION The Company's three operating and reportable segments, HPA, CSG, and ACG, are based on the organizational structure and information reviewed by the Company's Chief Executive Officer, who is also the Company's chief operating decision maker ("CODM"). The CODM allocates resources and evaluates the performance of each of the three operating segments primarily based on operating income. The Company’s manufacturing facilities service and provide benefit to all three operating segments and the operating costs of the facilities are reflected in the cost of goods sold of each operating segment, on the basis of product cost. The Company’s operating segments do not record intercompany revenue. The Company does not allocate gains and losses from investments, interest expense, other income (expense), or taxes to operating segments. The CODM does not evaluate operating segments using discrete asset information. HPA is a leading global supplier of radio frequency ("RF") and power management solutions for automotive, defense and aerospace, cellular infrastructure, broadband, industrial, enterprise and consumer markets. HPA leverages a diverse portfolio of differentiated technologies and products to support multiyear growth trends, including electrification, renewable energy, the increasing semiconductor spend in defense and aerospace, and 5G and 6G network infrastructure. CSG is a leading global supplier of connectivity and sensor solutions, with broad expertise spanning ultra-wideband, Matter ® , Bluetooth ® Low Energy, Zigbee ® , Thread ® , Wi-Fi ® , cellular Internet of Things, microelectromechanical system-based sensors and bulk acoustic wave-based sensors. CSG’s markets include home and consumer electronics, industrial automation, automotive, smartphones, wearables, and industrial and enterprise access points. ACG is a leading global supplier of cellular RF solutions for smartphones, wearables, laptops, tablets and other devices. ACG leverages world-class technology and systems-level expertise to deliver a broad portfolio of high performance cellular products to the world's leading smartphone and consumer electronics companies. The "All other" category includes operating expenses such as stock-based compensation expense, amortization of intangible assets, restructuring-related charges, acquisition and integration-related costs, goodwill impairment, charges associated with a long-term capacity reservation agreement, gain (loss) on disposal of business and assets and other miscellaneous corporate overhead expenses that the Company does not allocate to its operating segments because these expenses are not included in the segment operating performance measures evaluated by the Company’s CODM. Except as discussed above regarding the "All other" category, the Company’s accounting policies for segment reporting are the same as for the Company as a whole. The following tables present details of the Company’s operating and reportable segments and a reconciliation of the "All other" category (in thousands): Three Months Ended Nine Months Ended December 30, 2023 December 31, 2022 December 30, 2023 December 31, 2022 Revenue: HPA $ 118,890 $ 155,011 $ 408,386 $ 594,094 CSG 108,898 96,810 311,783 392,454 ACG 846,073 491,460 2,108,349 1,950,148 Total revenue $ 1,073,861 $ 743,281 $ 2,828,518 $ 2,936,696 Operating (loss) income: HPA $ 1,578 $ 29,836 $ 50,988 $ 181,102 CSG (25,590) (31,145) (73,476) (29,926) ACG 263,792 99,862 593,595 569,439 All other (281,349) (89,824) (509,384) (348,465) Operating (loss) income (41,569) 8,729 61,723 372,150 Interest expense (17,581) (17,066) (51,963) (51,222) Other income, net 15,359 5,562 34,286 2,714 (Loss) income before income taxes $ (43,791) $ (2,775) $ 44,046 $ 323,642 Three Months Ended Nine Months Ended December 30, 2023 December 31, 2022 December 30, 2023 December 31, 2022 Reconciliation of "All other" category: Stock-based compensation expense $ (21,755) $ (19,708) $ (99,253) $ (86,911) Amortization of intangible assets (29,787) (32,844) (90,622) (99,283) Restructuring-related charges (1) (6,075) (27,385) (37,229) (32,479) Acquisition and integration-related costs (2,529) (6,296) (4,576) (21,246) Goodwill impairment (2) (173,414) — (221,414) — Charges associated with a long-term capacity reservation agreement (3) (51,864) — (51,864) (110,000) Other 4,075 (3,591) (4,426) 1,454 Loss from operations for "All other" $ (281,349) $ (89,824) $ (509,384) $ (348,465) (1) Refer to Note 9 for additional information. (2) Refer to Note 3 for additional information. (3) Refer to Note 7 for additional information.

Income Taxes

Income Taxes	9 Months Ended
Income Taxes	Dec. 30, 2023
Income Tax Disclosure [Abstract]
INCOME TAXES	INCOME TAXES The Company’s income tax expense was $83.1 million and $117.1 million for the three and nine months ended December 30, 2023, respectively, and income tax expense was $13.2 million and $82.1 million for the three and nine months ended December 31, 2022, respectively. The Company’s effective tax rate was (189.9)% and 265.9% for the three and nine months ended December 30, 2023, respectively, and (474.1)% and 25.4% for the three and nine months ended December 31, 2022, respectively. The Company's effective tax rate for the three and nine months ended December 30, 2023 differed from the statutory rate primarily due to tax rate differences in foreign jurisdictions, global intangible low tax income ("GILTI"), domestic tax credits generated, discrete charges and tax items recorded during the periods including effects of non-deductible goodwill impairment charges within the CSG segment. A discrete tax expense of $40.2 million and $45.7 million was recorded during the three and nine months ended December 30, 2023, respectively. The discrete tax expense for the three months ended December 30, 2023 primarily related to the tax impacts of the Company’s reversal of its permanent reinvestment assertion, sale of its non-core biotechnology business, termination of a long-term capacity reservation agreement, and the correlative effects on GILTI. The discrete tax expense for the three and nine months ended December 30, 2023 was also impacted by foreign currency gains recognized for tax purposes. The Company continually evaluates its global cash needs and has historically asserted that some of its unremitted foreign earnings were permanently reinvested. During the three months ended December 30, 2023, the Company entered into a definitive agreement to sell its assembly and test facilities in China (refer to Note 9 for additional information), and it was determined the Company could no longer support its permanent reinvestment assertion on related, unremitted earnings. In relation to the reversal of its permanent reinvestment assertion, the Company recorded a $28.2 million discrete tax expense during the third quarter of fiscal 2024, and as of December 30, 2023, the Company no longer asserts that any of the earnings of its foreign subsidiaries are permanently reinvested. The Company's effective tax rate for the three and nine months ended December 31, 2022 differed from the statutory rate primarily due to tax rate differences in foreign jurisdictions, GILTI, domestic tax credits generated and discrete tax items recorded during the periods. A discrete tax expense of $2.2 million and discrete tax benefit of $10.4 million was recorded during the three and nine months ended December 31, 2022, respectively. The discrete tax expense for the three months ended December 31, 2022 primarily resulted from foreign currency gains recognized for tax purposes. The discrete tax benefit for the nine months ended December 31, 2022 primarily resulted from certain charges associated with a long-term capacity reservation agreement, partially offset by foreign currency gains recognized for tax purposes.

Net Income Per Share

Net Income Per Share	9 Months Ended
Net Income Per Share	Dec. 30, 2023
Earnings Per Share [Abstract]
NET INCOME PER SHARE	NET (LOSS) INCOME PER SHARE The following table sets forth the computation of basic and diluted net (loss) income per share (in thousands, except per share data): Three Months Ended Nine Months Ended December 30, 2023 December 31, 2022 December 30, 2023 December 31, 2022 Numerator: Numerator for basic and diluted net (loss) income per share — net (loss) income available to common stockholders $ (126,938) $ (15,931) $ (73,057) $ 241,568 Denominator: Denominator for basic net (loss) income per share — weighted-average shares 97,152 100,943 97,905 103,039 Effect of dilutive securities: Stock-based awards — — — 773 Denominator for diluted net (loss) income per share — adjusted weighted-average shares and assumed conversions 97,152 100,943 97,905 103,812 Basic net (loss) income per share $ (1.31) $ (0.16) $ (0.75) $ 2.34 Diluted net (loss) income per share $ (1.31) $ (0.16) $ (0.75) $ 2.33 In the computation of net loss per share for the three and nine months ended December 30, 2023, approximately 2.2 million and 1.6 million shares, respectively, of outstanding stock-based awards were excluded because the effect of their inclusion would have been anti-dilutive. In the computation of net loss per share for the three months ended December 31, 2022, approximately 2.0 million shares of outstanding stock-based awards were excluded because the effect of their inclusion would have been anti-dilutive. In the computation of diluted net income per share for the nine months ended December 31, 2022, approximately 0.9 million shares of outstanding stock-based awards were excluded because the effect of their inclusion would have been anti-dilutive.

Subsequent Events

Subsequent Events	9 Months Ended
Subsequent Events	Dec. 30, 2023
Subsequent Events [Abstract]
Subsequent Event [Text Block]	SUBSEQUENT EVENT On January 22, 2024, the Company entered into a definitive agreement to acquire Anokiwave, Inc. ("Anokiwave"). Anokiwave is a leading supplier of high performance silicon integrated circuits for intelligent active array antennas for defense and aerospace, satellite communication and 5G applications. The acquisition is expected to be completed during the fourth quarter of fiscal 2024, subject to certain customary closing conditions, and is expected to be funded with cash on hand.

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
Pay vs Performance Disclosure - USD ($) $ in Thousands	Dec. 30, 2023	Dec. 31, 2022	Dec. 30, 2023	Dec. 31, 2022
Pay vs Performance Disclosure
Numerator for basic and diluted net income (loss) per share — net income (loss) available to common stockholders	$ (126,938)	$ (15,931)	$ (73,057)	$ 241,568

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
Insider Trading Arrangements	Dec. 30, 2023
Trading Arrangements, by Individual
Material Terms of Trading Arrangement	OTHER INFORMATION. Rule 10b5-1 and Non-Rule 10b5-1 Trading Arrangements
Non-Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Terminated	false

Long-Term Debt Fair Value of De

Long-Term Debt Fair Value of Debt (Policies)	9 Months Ended
Long-Term Debt Fair Value of Debt (Policies)	Dec. 30, 2023
Debt Disclosure [Abstract]
Fair value of debt [Policy Text Block]	The Company's debt is carried at amortized cost and is measured at fair value quarterly for disclosure purposes. The estimated fair value of the 2024 Notes, the 2029 Notes and the 2031 Notes as of December 30, 2023 was $462.1 million, $803.9 million and $602.2 million, respectively (compared to the outstanding principal amount of $481.3 million, $850.0 million and $700.0 million, respectively). The estimated fair value of the 2024 Notes, the 2029 Notes and the 2031 Notes as of April 1, 2023 was $464.2 million, $785.9 million and $565.3 million, respectively (compared to the outstanding principal amount of $500.0 million, $850.0 million and $700.0 million, respectively). The Company considers its debt to be Level 2 in the fair value hierarchy. Fair values are estimated based on quoted market prices for identical or similar instruments. The 2024 Notes, the 2029 Notes and the 2031 Notes currently trade over-the-counter, and the fair values were estimated based upon the value of the last trade at the end of the period.

Operating Segment Information S

Operating Segment Information Segment Policy (Policies)	9 Months Ended
Operating Segment Information Segment Policy (Policies)	Dec. 30, 2023
Segment Reporting [Abstract]
Segment Reporting, Policy [Policy Text Block]	The Company's three operating and reportable segments, HPA, CSG, and ACG, are based on the organizational structure and information reviewed by the Company's Chief Executive Officer, who is also the Company's chief operating decision maker ("CODM"). The CODM allocates resources and evaluates the performance of each of the three operating segments primarily based on operating income. The Company’s manufacturing facilities service and provide benefit to all three operating segments and the operating costs of the facilities are reflected in the cost of goods sold of each operating segment, on the basis of product cost. The Company’s operating segments do not record intercompany revenue. The Company does not allocate gains and losses from investments, interest expense, other income (expense), or taxes to operating segments. The CODM does not evaluate operating segments using discrete asset information. HPA is a leading global supplier of radio frequency ("RF") and power management solutions for automotive, defense and aerospace, cellular infrastructure, broadband, industrial, enterprise and consumer markets. HPA leverages a diverse portfolio of differentiated technologies and products to support multiyear growth trends, including electrification, renewable energy, the increasing semiconductor spend in defense and aerospace, and 5G and 6G network infrastructure. CSG is a leading global supplier of connectivity and sensor solutions, with broad expertise spanning ultra-wideband, Matter ® , Bluetooth ® Low Energy, Zigbee ® , Thread ® , Wi-Fi ® , cellular Internet of Things, microelectromechanical system-based sensors and bulk acoustic wave-based sensors. CSG’s markets include home and consumer electronics, industrial automation, automotive, smartphones, wearables, and industrial and enterprise access points. ACG is a leading global supplier of cellular RF solutions for smartphones, wearables, laptops, tablets and other devices. ACG leverages world-class technology and systems-level expertise to deliver a broad portfolio of high performance cellular products to the world's leading smartphone and consumer electronics companies. The "All other" category includes operating expenses such as stock-based compensation expense, amortization of intangible assets, restructuring-related charges, acquisition and integration-related costs, goodwill impairment, charges associated with a long-term capacity reservation agreement, gain (loss) on disposal of business and assets and other miscellaneous corporate overhead expenses that the Company does not allocate to its operating segments because these expenses are not included in the segment operating performance measures evaluated by the Company’s CODM. Except as discussed above regarding the "All other" category, the Company’s accounting policies for segment reporting are the same as for the Company as a whole.

Inventories (Tables)

Inventories (Tables)	9 Months Ended
Inventories (Tables)	Dec. 30, 2023
Inventory Disclosure [Abstract]
Components of inventories	The components of inventories, net of reserves, are as follows (in thousands): December 30, 2023 April 1, 2023 Raw materials $ 214,530 $ 264,367 Work in process 372,554 345,545 Finished goods 139,603 186,684 Total inventories $ 726,687 $ 796,596

Goodwill and Intangible Assets

Goodwill and Intangible Assets (Tables)	9 Months Ended
Goodwill and Intangible Assets (Tables)	Dec. 30, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Goodwill [Table Text Block]	The changes in the carrying amount of goodwill are as follows (in thousands): HPA CSG ACG Total Balance as of April 1, 2023 (1) $ 501,602 $ 525,351 $ 1,733,860 $ 2,760,813 Goodwill impairment — (221,414) — (221,414) Effect of changes in foreign currency exchange rates — 1,062 — 1,062 Balance as of December 30, 2023 (1) $ 501,602 $ 304,999 $ 1,733,860 $ 2,540,461 (1) The Company’s goodwill balance is presented net of accumulated impairment losses and write-offs totaling $903.4 million and $682.0 million as of December 30, 2023 and April 1, 2023, respectively, which were recognized in fiscal years 2009, 2013, 2014, 2022, 2023 and 2024.
Schedule of finite-lived and indefinite-lived intangible assets [Table Text Block]	The following summarizes information regarding the gross carrying amounts and accumulated amortization of intangible assets (in thousands): December 30, 2023 April 1, 2023 Gross Accumulated Gross Accumulated Developed technology $ 876,285 $ 462,259 $ 872,106 $ 382,448 Customer relationships 87,040 62,872 104,616 67,485 Technology licenses 54,287 2,128 1,664 513 Trade names 910 910 910 789 In-process research and development 9,610 N/A 9,642 N/A Total (1) $ 1,028,132 $ 528,169 $ 988,938 $ 451,235 (1) Amounts include the impact of foreign currency translation.

Investments and Fair Value of_2

Investments and Fair Value of Financial Instruments (Tables)	9 Months Ended
	Dec. 30, 2023
Investments and Fair Value Measurements [Abstract]
Fair value of the financial assets measured at fair value on a recurring basis	The following table sets forth, by level within the fair value hierarchy, financial assets and liabilities measured on a recurring basis (in thousands): Total Quoted Prices In Significant Other Significant December 30, 2023 Marketable equity securities $ 812 $ 812 $ — $ — Invested funds in deferred compensation plan (1) 48,386 48,386 — — April 1, 2023 Marketable equity securities $ 1,094 $ 1,094 $ — $ — Invested funds in deferred compensation plan (1) 40,653 40,653 — — Contingent earn-out liability (2) (31,250) — — (31,250) (1) Invested funds under the Company's non-qualified deferred compensation plan are held in a rabbi trust and consist of mutual funds. The fair value of the mutual funds is calculated using the net asset value per share determined by quoted active market prices of the underlying investments. (2) The fair value of the contingent consideration liability which related to the acquisition of United Silicon Carbide, Inc. was equal to the maximum amount payable at April 1, 2023 and was subsequently paid in the first quarter of fiscal 2024.

Debt (Tables)

Debt (Tables)	9 Months Ended
Debt (Tables)	Dec. 30, 2023
Debt Disclosure [Abstract]
Schedule of Long-term Debt Instruments	The following table summarizes the outstanding debt (in thousands): December 30, 2023 April 1, 2023 1.750% senior notes due 2024 $ 481,333 $ 500,000 4.375% senior notes due 2029 850,000 850,000 3.375% senior notes due 2031 700,000 700,000 Finance leases and other 1,255 1,666 Unamortized premium, discount and issuance costs, net (2,186) (3,283) Total debt 2,030,402 2,048,383 Less current portion of debt (479,964) (310) Total long-term debt $ 1,550,438 $ 2,048,073

Revenue (Tables)

Revenue (Tables)	9 Months Ended
Revenue (Tables)	Dec. 30, 2023
Revenue from Contract with Customer [Abstract]
Disaggregation of Revenue	Revenue to customers by geographic region (based on the location of the customers' headquarters) is summarized as follows (in thousands): Three Months Ended Nine Months Ended December 30, 2023 December 31, 2022 December 30, 2023 December 31, 2022 United States $ 652,477 $ 459,194 $ 1,667,048 $ 1,470,231 China 201,172 124,799 541,878 630,012 Other Asia 144,584 72,002 355,313 390,690 Taiwan 60,775 53,072 192,793 274,707 Europe 14,853 34,214 71,486 171,056 Total revenue $ 1,073,861 $ 743,281 $ 2,828,518 $ 2,936,696

Restructuring and Related Act_2

Restructuring and Related Activities (Tables)	9 Months Ended
Restructuring and Related Activities (Tables)	Dec. 30, 2023
Restructuring and Related Activities [Abstract]
Schedule of restructuring activity	The following tables summarize the charges resulting from the 2023 Restructuring Initiatives (in thousands): Three Months Ended December 30, 2023 Nine Months Ended December 30, 2023 Cost of Goods Sold Other Operating Expense Total Cost of Goods Sold Other Operating Expense Total Contract termination and other costs (1) $ (250) $ 773 $ 523 $ 19,028 $ 3,530 $ 22,558 Asset impairment costs (2) — 2,341 2,341 2,159 6,627 8,786 One-time employee termination benefits — 7 7 — 2,681 2,681 Total $ (250) $ 3,121 $ 2,871 $ 21,187 $ 12,838 $ 34,025 Three Months Ended December 31, 2022 Nine Months Ended December 31, 2022 Cost of Goods Sold Other Operating Expense Total Cost of Goods Sold Other Operating Expense Total Contract termination and other costs $ 3,600 $ 11,509 $ 15,109 $ 3,600 $ 13,433 $ 17,033 Asset impairment costs (2) — 12,899 12,899 — 12,899 12,899 One-time employee termination benefits (1) — (623) (623) — 2,547 2,547 Total $ 3,600 $ 23,785 $ 27,385 $ 3,600 $ 28,879 $ 32,479 (1) Includes reversal due to adjustment of previously accrued restructuring charges. (2) Includes the adjustment of certain property and equipment to reflect its fair value.
Restructuring Liabilities Rollforward	The following table summarizes the activity related to the Company's restructuring liabilities for the nine months ended December 30, 2023 (in thousands): One-Time Employee Termination Benefits Contract Termination and Other Costs Total Accrued restructuring balance as of April 1, 2023 $ — $ 5,248 $ 5,248 Costs incurred and charged to expense 2,681 25,762 28,443 Cash payments (2,604) (16,571) (19,175) Accrued restructuring balance as of December 30, 2023 $ 77 $ 14,439 $ 14,516 The accrued restructuring balances as of December 30, 2023 represent estimated future cash payments required to satisfy the Company's remaining obligations, the majority of which are expected to be paid in the next twelve months.

Operating Segment Information (

Operating Segment Information (Tables)	9 Months Ended
Operating Segment Information (Tables)	Dec. 30, 2023
Segment Reporting [Abstract]
Summary of details of reportable segments	The following tables present details of the Company’s operating and reportable segments and a reconciliation of the "All other" category (in thousands): Three Months Ended Nine Months Ended December 30, 2023 December 31, 2022 December 30, 2023 December 31, 2022 Revenue: HPA $ 118,890 $ 155,011 $ 408,386 $ 594,094 CSG 108,898 96,810 311,783 392,454 ACG 846,073 491,460 2,108,349 1,950,148 Total revenue $ 1,073,861 $ 743,281 $ 2,828,518 $ 2,936,696 Operating (loss) income: HPA $ 1,578 $ 29,836 $ 50,988 $ 181,102 CSG (25,590) (31,145) (73,476) (29,926) ACG 263,792 99,862 593,595 569,439 All other (281,349) (89,824) (509,384) (348,465) Operating (loss) income (41,569) 8,729 61,723 372,150 Interest expense (17,581) (17,066) (51,963) (51,222) Other income, net 15,359 5,562 34,286 2,714 (Loss) income before income taxes $ (43,791) $ (2,775) $ 44,046 $ 323,642
Summary of reconciliation of "All other" category	Three Months Ended Nine Months Ended December 30, 2023 December 31, 2022 December 30, 2023 December 31, 2022 Reconciliation of "All other" category: Stock-based compensation expense $ (21,755) $ (19,708) $ (99,253) $ (86,911) Amortization of intangible assets (29,787) (32,844) (90,622) (99,283) Restructuring-related charges (1) (6,075) (27,385) (37,229) (32,479) Acquisition and integration-related costs (2,529) (6,296) (4,576) (21,246) Goodwill impairment (2) (173,414) — (221,414) — Charges associated with a long-term capacity reservation agreement (3) (51,864) — (51,864) (110,000) Other 4,075 (3,591) (4,426) 1,454 Loss from operations for "All other" $ (281,349) $ (89,824) $ (509,384) $ (348,465) (1) Refer to Note 9 for additional information. (2) Refer to Note 3 for additional information. (3) Refer to Note 7 for additional information.

Net Income Per Share (Tables)

Net Income Per Share (Tables)	9 Months Ended
Net Income Per Share (Tables)	Dec. 30, 2023
Earnings Per Share [Abstract]
Reconciliation of the numerators and denominators in the computation of basic and diluted net loss per share	The following table sets forth the computation of basic and diluted net (loss) income per share (in thousands, except per share data): Three Months Ended Nine Months Ended December 30, 2023 December 31, 2022 December 30, 2023 December 31, 2022 Numerator: Numerator for basic and diluted net (loss) income per share — net (loss) income available to common stockholders $ (126,938) $ (15,931) $ (73,057) $ 241,568 Denominator: Denominator for basic net (loss) income per share — weighted-average shares 97,152 100,943 97,905 103,039 Effect of dilutive securities: Stock-based awards — — — 773 Denominator for diluted net (loss) income per share — adjusted weighted-average shares and assumed conversions 97,152 100,943 97,905 103,812 Basic net (loss) income per share $ (1.31) $ (0.16) $ (0.75) $ 2.34 Diluted net (loss) income per share $ (1.31) $ (0.16) $ (0.75) $ 2.33

Inventories (Details)

Inventories (Details) - USD ($) $ in Thousands	Dec. 30, 2023	Apr. 01, 2023
Components of inventories
Raw materials	$ 214,530	$ 264,367
Work in process	372,554	345,545
Finished goods	139,603	186,684
Total inventories	$ 726,687	$ 796,596

Business Acquisition Narrative

Business Acquisition Narrative (Details) - USD ($) $ in Thousands	Dec. 30, 2023	Apr. 01, 2023
Business Acquisition [Line Items]
Goodwill	$ 2,540,461	$ 2,760,813

Goodwill and Intangible Asset_2

Goodwill and Intangible Assets (Details) - USD ($) $ in Thousands	3 Months Ended			9 Months Ended
	Dec. 30, 2023	Sep. 30, 2023	Dec. 31, 2022	Dec. 30, 2023	Dec. 31, 2022	Apr. 01, 2023
Goodwill and Intangible Assets [Line Items]
Intangible assets amortization				$ 92,308	$ 99,476
Goodwill	$ 2,540,461			2,540,461		$ 2,760,813
Goodwill, Impairment Loss	173,414	$ 48,000	$ 0	221,414	$ 0
Goodwill, Accumulated impairment losses and write-offs	903,400			903,400		682,000
Accumulated Amortization	528,169			528,169		451,235
Goodwill, Foreign Currency Translation Gain (Loss)				1,062
Gross Carrying Amount	1,028,132			1,028,132		988,938
Technology licenses
Goodwill and Intangible Assets [Line Items]
Gross Carrying Amount	54,287			54,287		1,664
Accumulated Amortization	2,128			2,128		513
Trade Names
Goodwill and Intangible Assets [Line Items]
Gross Carrying Amount	910			910		910
Accumulated Amortization	910			910		789
Developed Technology
Goodwill and Intangible Assets [Line Items]
Gross Carrying Amount	876,285			876,285		872,106
Accumulated Amortization	462,259			462,259		382,448
Customer Relationships
Goodwill and Intangible Assets [Line Items]
Gross Carrying Amount	87,040			87,040		104,616
Accumulated Amortization	62,872			62,872		67,485
In-process research and development
Goodwill and Intangible Assets [Line Items]
IPRD	9,610			9,610		9,642
HPA
Goodwill and Intangible Assets [Line Items]
Goodwill	501,602			501,602		501,602
Goodwill, Impairment Loss				0
Goodwill, Foreign Currency Translation Gain (Loss)				0
CSG
Goodwill and Intangible Assets [Line Items]
Goodwill	304,999			304,999		525,351
Goodwill, Impairment Loss				221,414
Goodwill, Foreign Currency Translation Gain (Loss)				1,062
ACG
Goodwill and Intangible Assets [Line Items]
Goodwill	$ 1,733,860			1,733,860		$ 1,733,860
Goodwill, Impairment Loss				0
Goodwill, Foreign Currency Translation Gain (Loss)				$ 0

Investments and Fair Value of_3

Investments and Fair Value of Financial Instruments (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 30, 2023	Dec. 31, 2022	Dec. 30, 2023	Dec. 31, 2022	Apr. 01, 2023
Investments and Fair Value of Financial Instruments
Document Period End Date			Dec. 30, 2023
Equity Method Investments	$ 17,500		$ 17,500		$ 20,400
Proceeds from Limited Partnership Investments	400	$ 200	3,200	$ 2,200
Gain (Loss) on Investments	600	$ 5,000	300	$ 4,700
Fair Value, Recurring [Member] \| United Silicon Carbide
Investments and Fair Value of Financial Instruments
Business Combination, Contingent Consideration, Liability, Noncurrent					(31,250)
Fair Value, Recurring [Member] \| Equity Securities
Investments and Fair Value of Financial Instruments
Marketable Securities	812		812		1,094
Fair Value, Recurring [Member] \| Mutual Fund
Investments and Fair Value of Financial Instruments
Deferred Compensation Plan Assets	48,386		48,386		40,653
Quoted Prices In Active Markets For Identical Assets (Level 1) \| Fair Value, Recurring [Member] \| United Silicon Carbide
Investments and Fair Value of Financial Instruments
Business Combination, Contingent Consideration, Liability, Noncurrent					0
Quoted Prices In Active Markets For Identical Assets (Level 1) \| Fair Value, Recurring [Member] \| Equity Securities
Investments and Fair Value of Financial Instruments
Marketable Securities	812		812		1,094
Quoted Prices In Active Markets For Identical Assets (Level 1) \| Fair Value, Recurring [Member] \| Mutual Fund
Investments and Fair Value of Financial Instruments
Deferred Compensation Plan Assets	48,386		48,386		40,653
Significant Other Observable Inputs (Level 2) \| Fair Value, Recurring [Member] \| United Silicon Carbide
Investments and Fair Value of Financial Instruments
Business Combination, Contingent Consideration, Liability, Noncurrent					0
Significant Other Observable Inputs (Level 2) \| Fair Value, Recurring [Member] \| Equity Securities
Investments and Fair Value of Financial Instruments
Marketable Securities	0		0		0
Significant Other Observable Inputs (Level 2) \| Fair Value, Recurring [Member] \| Mutual Fund
Investments and Fair Value of Financial Instruments
Deferred Compensation Plan Assets	0		0		0
Fair Value, Inputs, Level 3 [Member] \| Fair Value, Recurring [Member] \| United Silicon Carbide
Investments and Fair Value of Financial Instruments
Business Combination, Contingent Consideration, Liability, Noncurrent					(31,250)
Fair Value, Inputs, Level 3 [Member] \| Fair Value, Recurring [Member] \| Equity Securities
Investments and Fair Value of Financial Instruments
Marketable Securities	0		0		0
Fair Value, Inputs, Level 3 [Member] \| Fair Value, Recurring [Member] \| Mutual Fund
Investments and Fair Value of Financial Instruments
Deferred Compensation Plan Assets	$ 0		$ 0		$ 0

Debt (Details)

Debt (Details) - USD ($)		3 Months Ended		9 Months Ended
Debt (Details) - USD ($)	Apr. 06, 2022	Dec. 30, 2023	Dec. 31, 2022	Dec. 30, 2023	Dec. 31, 2022	Jun. 29, 2024	Mar. 30, 2024	Dec. 04, 2023	Apr. 01, 2023	Dec. 14, 2021	Sep. 29, 2020	Jun. 11, 2020	Dec. 20, 2019	Sep. 30, 2019
Debt Instrument [Line Items]
Long-term debt		$ 1,550,438,000		$ 1,550,438,000					$ 2,048,073,000
Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net		(2,186,000)		(2,186,000)					(3,283,000)
Debt, Long-Term and Short-Term, Combined Amount		2,030,402,000		2,030,402,000					2,048,383,000
Long-term Debt, Current Maturities		(479,964,000)	$ (310,000)	(479,964,000)	$ (310,000)				(310,000)
Interest Expense, Borrowings		18,200,000	18,100,000	54,200,000	54,200,000
Interest Costs Capitalized		600,000	1,000,000	2,300,000	3,000,000
Interest expense		17,581,000	17,066,000	51,963,000	51,222,000
Line of Credit Facility, Remaining Borrowing Capacity											$ 500,000,000
Debt Instrument, Repurchased Face Amount								$ 18,700,000
Gain (Loss) on Repurchase of Debt Instrument		700,000
4.375% senior notes due 2029
Debt Instrument [Line Items]
Debt Instrument, Face Amount		850,000,000		850,000,000					850,000,000			$ 300,000,000	$ 200,000,000	$ 350,000,000
Interest Paid, Including Capitalized Interest, Operating and Investing Activities		18,600,000		37,200,000
Debt Instrument, Interest Rate, Stated Percentage														4.375%
4.375% senior notes due 2029 \| Fair Value, Inputs, Level 2 [Member]
Debt Instrument [Line Items]
Long-term Debt, Fair Value		803,900,000		803,900,000					785,900,000
3.375% Senior Notes due 2031 [Member]
Debt Instrument [Line Items]
Debt Instrument, Face Amount		700,000,000		700,000,000					700,000,000		$ 700,000,000
Interest Paid, Including Capitalized Interest, Operating and Investing Activities			0	11,800,000	11,800,000
Debt Instrument, Interest Rate, Stated Percentage											3.375%
3.375% Senior Notes due 2031 [Member] \| Fair Value, Inputs, Level 2 [Member]
Debt Instrument [Line Items]
Long-term Debt, Fair Value		602,200,000		602,200,000					565,300,000
Senior Notes Due 2024 1.750%
Debt Instrument [Line Items]
Debt Instrument, Face Amount		481,333,000		481,333,000					500,000,000	$ 500,000,000
Interest Paid, Including Capitalized Interest, Operating and Investing Activities		4,200,000	$ 4,400,000	8,600,000	$ 8,800,000
Debt Instrument, Interest Rate, Stated Percentage										1.75%
Senior Notes Due 2024 1.750% \| Fair Value, Inputs, Level 2 [Member]
Debt Instrument [Line Items]
Long-term Debt, Fair Value		$ 462,100,000		$ 462,100,000					464,200,000
Credit Agreement \| Federal Funds Rate
Debt Instrument [Line Items]
Debt Instrument, Basis Spread on Variable Rate	0.50%
Credit Agreement \| Base Rate [Member]
Debt Instrument [Line Items]
Debt Instrument, Basis Spread on Variable Rate	1%
Credit Agreement \| Maximum [Member]
Debt Instrument [Line Items]
Debt Instrument, Consolidated Leverage Ratio		400%		400%
Credit Agreement \| Maximum [Member] \| Subsequent Event [Member]
Debt Instrument [Line Items]
Debt Instrument, Consolidated Leverage Ratio						300%	350%
Credit Agreement \| Maximum [Member] \| Base Rate [Member]
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Stated Percentage	0.25%
Credit Agreement \| Maximum [Member] \| Loan Lending Commitment Arrangement Fees [Member]
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Stated Percentage	0.20%
Credit Agreement \| Maximum [Member] \| Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Stated Percentage	1.25%
Credit Agreement \| Minimum [Member] \| Base Rate [Member]
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Stated Percentage	0%
Credit Agreement \| Minimum [Member] \| Loan Lending Commitment Arrangement Fees [Member]
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Stated Percentage	0.15%
Credit Agreement \| Minimum [Member] \| Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Stated Percentage	1%
Capital Lease Obligations
Debt Instrument [Line Items]
Long-term debt		$ 1,255,000		$ 1,255,000					$ 1,666,000
Revolving Credit Facility [Member]
Debt Instrument [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity											$ 300,000,000
Proceeds from Lines of Credit				$ 0

Stock Repurchases (Details)

Stock Repurchases (Details) - USD ($) $ in Thousands, shares in Millions	3 Months Ended		9 Months Ended
	Dec. 30, 2023	Dec. 31, 2022	Dec. 30, 2023	Dec. 31, 2022	Nov. 02, 2022
Class of Stock [Line Items]
Stock Repurchased During Period, Shares	1.1	2.2	3.1	7.2
Stock Repurchased During Period, Value	$ 100,812	$ 201,633	$ 301,978	$ 711,732
Stock Repurchase Program, Remaining Authorized Repurchase Amount	$ 1,405,000		$ 1,405,000
Document Period End Date			Dec. 30, 2023
November 2, 2022 Program
Class of Stock [Line Items]
Stock Repurchase Program, Authorized Amount					$ 2,000,000

Commitments and Contingent Li_2

Commitments and Contingent Liabilities (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Dec. 30, 2023	Jul. 02, 2022	Sep. 30, 2023
Unrecorded Unconditional Purchase Obligation [Line Items]
Charges associated with a long-term capacity reservation agreement (3)	$ 65	$ 110	$ 0

Revenue (Details)

Revenue (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
Revenue (Details) - USD ($) $ in Thousands	Dec. 30, 2023	Dec. 31, 2022	Dec. 30, 2023	Dec. 31, 2022
Disaggregation of Revenue
Revenues	$ 1,073,861	$ 743,281	$ 2,828,518	$ 2,936,696
China
Disaggregation of Revenue
Revenues	201,172	124,799	541,878	630,012
Taiwan
Disaggregation of Revenue
Revenues	60,775	53,072	192,793	274,707
United States
Disaggregation of Revenue
Revenues	652,477	459,194	1,667,048	1,470,231
Europe
Disaggregation of Revenue
Revenues	14,853	34,214	71,486	171,056
Other Asia
Disaggregation of Revenue
Revenues	$ 144,584	$ 72,002	$ 355,313	$ 390,690

Restructuring and Related Act_3

Restructuring and Related Activities (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended		15 Months Ended
	Dec. 30, 2023	Dec. 31, 2022	Dec. 30, 2023	Dec. 31, 2022	Dec. 30, 2023	Apr. 01, 2023
Restructuring and Related Activities [Abstract]
Restructuring Charges			$ 28,443
Restructuring
Restructuring Charges			28,443
Payments for Restructuring			(19,175)
Restructuring Reserve	$ 14,516		14,516		$ 14,516	$ 5,248
One-time Employee Termination Benefits
Restructuring and Related Activities [Abstract]
Restructuring Charges			2,681
Restructuring
Restructuring Charges			2,681
Payments for Restructuring			(2,604)
Restructuring Reserve	77		77		77	0
Lease and other contract terminations
Restructuring and Related Activities [Abstract]
Restructuring Charges			25,762
Restructuring
Restructuring Charges			25,762
Payments for Restructuring			(16,571)
Restructuring Reserve	14,439		14,439		14,439	$ 5,248
fiscal year 2023
Restructuring and Related Activities [Abstract]
Restructuring Charges	2,871	$ 27,385	34,025	$ 32,479
Restructuring
Restructuring Charges	2,871	27,385	34,025	32,479
fiscal year 2023 \| One-time Employee Termination Benefits
Restructuring and Related Activities [Abstract]
Restructuring Charges	7	(623)	2,681	2,547
Restructuring
Restructuring Charges	7	(623)	2,681	2,547
fiscal year 2023 \| impairment charges
Restructuring and Related Activities [Abstract]
Restructuring Charges	2,341	12,899	8,786	12,899
Restructuring
Restructuring Charges	2,341	12,899	8,786	12,899
fiscal year 2023 \| Lease and other contract terminations
Restructuring and Related Activities [Abstract]
Restructuring Charges	523	15,109	22,558	17,033
Restructuring
Restructuring Charges	$ 523	15,109	22,558	17,033
Fiscal year 2024
Restructuring
Restructuring and Related Activities, Description	the Company entered into a definitive agreement with a global advanced contract manufacturer (the "Purchaser"), to sell its assembly and test facilities in Beijing and Dezhou, China (the "2024 Restructuring Initiative")
Other operating expense \| fiscal year 2023
Restructuring and Related Activities [Abstract]
Restructuring Charges	$ 3,121	23,785	12,838	28,879	160,500
Restructuring
Restructuring Charges	3,121	23,785	12,838	28,879	$ 160,500
Other operating expense \| fiscal year 2023 \| One-time Employee Termination Benefits
Restructuring and Related Activities [Abstract]
Restructuring Charges	7	(623)	2,681	2,547
Restructuring
Restructuring Charges	7	(623)	2,681	2,547
Other operating expense \| fiscal year 2023 \| impairment charges
Restructuring and Related Activities [Abstract]
Restructuring Charges	2,341	12,899	6,627	12,899
Restructuring
Restructuring Charges	2,341	12,899	6,627	12,899
Other operating expense \| fiscal year 2023 \| Lease and other contract terminations
Restructuring and Related Activities [Abstract]
Restructuring Charges	773	11,509	3,530	13,433
Restructuring
Restructuring Charges	773	11,509	3,530	13,433
Cost of goods sold \| fiscal year 2023
Restructuring and Related Activities [Abstract]
Restructuring Charges	(250)	3,600	21,187	3,600
Restructuring
Restructuring Charges	(250)	3,600	21,187	3,600
Cost of goods sold \| fiscal year 2023 \| One-time Employee Termination Benefits
Restructuring and Related Activities [Abstract]
Restructuring Charges	0	0	0	0
Restructuring
Restructuring Charges	0	0	0	0
Cost of goods sold \| fiscal year 2023 \| impairment charges
Restructuring and Related Activities [Abstract]
Restructuring Charges	0	0	2,159	0
Restructuring
Restructuring Charges	0	0	2,159	0
Cost of goods sold \| fiscal year 2023 \| Lease and other contract terminations
Restructuring and Related Activities [Abstract]
Restructuring Charges	(250)	3,600	19,028	3,600
Restructuring
Restructuring Charges	$ (250)	$ 3,600	$ 19,028	$ 3,600

Operating Segment Information_2

Operating Segment Information (Details) - USD ($) $ in Thousands	3 Months Ended				6 Months Ended	9 Months Ended
	Dec. 30, 2023	Sep. 30, 2023	Dec. 31, 2022	Jul. 02, 2022	Sep. 30, 2023	Dec. 30, 2023	Dec. 31, 2022
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Document Period End Date						Dec. 30, 2023
Summary of details of reportable segments
Revenues	$ 1,073,861		$ 743,281			$ 2,828,518	$ 2,936,696
Income from operations:
Operating (loss) income	(41,569)		8,729			61,723	372,150
Interest expense	17,581		17,066			51,963	51,222
Other income (expense), net	15,359		5,562			34,286	2,714
(Loss) income before income taxes	(43,791)		(2,775)			44,046	323,642
Stock-based compensation expense						(99,253)	(86,911)
Amortization of intangible assets						(92,308)	(99,476)
Restructuring Charges						(28,443)
Charges associated with a long-term capacity reservation agreement (3)	65,000			$ 110,000	$ 0
Goodwill, Impairment Loss	(173,414)	$ (48,000)	0			(221,414)	0
HPA
Income from operations:
Goodwill, Impairment Loss						0
CSG
Income from operations:
Goodwill, Impairment Loss						(221,414)
ACG
Income from operations:
Goodwill, Impairment Loss						0
Operating Segments \| HPA
Summary of details of reportable segments
Revenues	118,890		155,011			408,386	594,094
Income from operations:
Operating (loss) income	1,578		29,836			50,988	181,102
Operating Segments \| CSG
Summary of details of reportable segments
Revenues	108,898		96,810			311,783	392,454
Income from operations:
Operating (loss) income	(25,590)		(31,145)			(73,476)	(29,926)
Operating Segments \| ACG
Summary of details of reportable segments
Revenues	846,073		491,460			2,108,349	1,950,148
Income from operations:
Operating (loss) income	263,792		99,862			593,595	569,439
All other
Income from operations:
Operating (loss) income	(281,349)		(89,824)			(509,384)	(348,465)
Stock-based compensation expense	(21,755)		(19,708)			(99,253)	(86,911)
Amortization of intangible assets	(29,787)		(32,844)			(90,622)	(99,283)
Restructuring Charges	(6,075)		(27,385)			(37,229)	(32,479)
Acquisition and integration-related costs	(2,529)		(6,296)			(4,576)	(21,246)
Charges associated with a long-term capacity reservation agreement (3)	51,864		0			51,864	110,000
Other	$ 4,075		$ (3,591)			$ (4,426)	$ 1,454

Income Taxes (Details)

Income Taxes (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
Income Taxes (Details) - USD ($) $ in Thousands	Dec. 30, 2023	Dec. 31, 2022	Dec. 30, 2023	Dec. 31, 2022
Income Tax Disclosure [Abstract]
Income tax benefit (expense)	$ 83,147	$ 13,156	$ 117,103	$ 82,074
Effective tax rate	(189.90%)	(474.10%)	265.90%	25.40%
Discrete tax expense (benefit)	$ (40,200)	$ (2,200)	$ (45,700)	$ 10,400
Restructuring
Discrete tax expense (benefit)	40,200	$ 2,200	$ 45,700	$ (10,400)
Fiscal year 2024
Income Tax Disclosure [Abstract]
Discrete tax expense (benefit)	(28,200)
Restructuring
Discrete tax expense (benefit)	$ 28,200

Net Income Per Share (Details)

Net Income Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 30, 2023	Dec. 31, 2022	Dec. 30, 2023	Dec. 31, 2022
Earnings Per Share [Abstract]
Document Period End Date			Dec. 30, 2023
Numerator:
Numerator for basic and diluted net income (loss) per share — net income (loss) available to common stockholders	$ (126,938)	$ (15,931)	$ (73,057)	$ 241,568
EPS Line Items
Denominator for basic net income (loss) per share — weighted average shares	97,152	100,943	97,905	103,039
Stock-based awards	0	0	0	773
Denominator for diluted net income (loss) per share — adjusted weighted average shares and assumed conversions	97,152	100,943	97,905	103,812
Basic net income (loss) per share (in dollars per share)	$ (1.31)	$ (0.16)	$ (0.75)	$ 2.34
Diluted net income (loss) per share (in dollars per share)	$ (1.31)	$ (0.16)	$ (0.75)	$ 2.33
Antidilutive shares excluded from the computation of diluted shares outstanding	2,200		1,600	900